Constance Thibault

2.5k total citations
98 papers, 1.2k citations indexed

About

Constance Thibault is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Constance Thibault has authored 98 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 50 papers in Oncology and 42 papers in Surgery. Recurrent topics in Constance Thibault's work include Bladder and Urothelial Cancer Treatments (34 papers), Cancer Immunotherapy and Biomarkers (30 papers) and Renal cell carcinoma treatment (26 papers). Constance Thibault is often cited by papers focused on Bladder and Urothelial Cancer Treatments (34 papers), Cancer Immunotherapy and Biomarkers (30 papers) and Renal cell carcinoma treatment (26 papers). Constance Thibault collaborates with scholars based in France, Italy and United States. Constance Thibault's co-authors include Stéphane Oudard, S. Nivatvongs, B. G. Wolff, Duane M. Ilstrup, P. M. Sagar, Yann Vano, Réza Elaidi, Mariana Mirabel, Giorgio Gandaglia and Elizabeth Fabre and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and European Heart Journal.

In The Last Decade

Constance Thibault

88 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Constance Thibault France 20 586 566 294 266 232 98 1.2k
Pınar Saip Türkiye 21 606 1.0× 520 0.9× 337 1.1× 288 1.1× 354 1.5× 115 1.6k
Kent Kanao Japan 19 387 0.7× 551 1.0× 419 1.4× 207 0.8× 166 0.7× 73 1.2k
Mehmet Alı Nahıt Şendur Türkiye 18 825 1.4× 446 0.8× 160 0.5× 292 1.1× 158 0.7× 183 1.4k
Begoña de las Heras Spain 11 608 1.0× 321 0.6× 229 0.8× 318 1.2× 149 0.6× 27 1.8k
Loı̈c Mourey France 16 565 1.0× 882 1.6× 271 0.9× 206 0.8× 277 1.2× 107 1.5k
Abdurrahman Işıkdoğan Türkiye 19 537 0.9× 424 0.7× 204 0.7× 204 0.8× 186 0.8× 146 1.2k
Florian Kocher Austria 18 498 0.8× 357 0.6× 130 0.4× 215 0.8× 160 0.7× 72 990
Daniel Swinson United Kingdom 17 562 1.0× 774 1.4× 357 1.2× 245 0.9× 233 1.0× 45 1.4k
Melissa Bersanelli Italy 19 821 1.4× 796 1.4× 192 0.7× 479 1.8× 295 1.3× 102 1.4k
Timothy R. Asmis Canada 19 758 1.3× 420 0.7× 237 0.8× 258 1.0× 208 0.9× 66 1.3k

Countries citing papers authored by Constance Thibault

Since Specialization
Citations

This map shows the geographic impact of Constance Thibault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Thibault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Thibault more than expected).

Fields of papers citing papers by Constance Thibault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Thibault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Thibault. The network helps show where Constance Thibault may publish in the future.

Co-authorship network of co-authors of Constance Thibault

This figure shows the co-authorship network connecting the top 25 collaborators of Constance Thibault. A scholar is included among the top collaborators of Constance Thibault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance Thibault. Constance Thibault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fléchon, Aude, G. Pignot, J. Rigaud, et al.. (2025). Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients. BJUI Compass. 6(7). e70056–e70056.
2.
Jouinot, Anne, Nadim Hamzaoui, Olivier Huillard, et al.. (2025). Predisposition to prostate cancer and clinical implications in a real-life cohort. European Journal of Human Genetics. 33(9). 1163–1172.
3.
Thibault, Constance, Loı̈c Mourey, Dominique Pasquier, et al.. (2025). OCTOPUS: A retrospective, multicenter study of real-world cabozantinib treatment of patients with advanced renal cell carcinoma in France—Subgroup analyses of treatment sequences and optimization.. Journal of Clinical Oncology. 43(5_suppl). 472–472. 1 indexed citations
4.
Roumiguié, M., Priscilla Léon, Évanguelos Xylinas, et al.. (2024). Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2024–2026 : tumeurs de la vessie n’infiltrant pas le muscle (TVNIM). 34(7). F272–F295. 1 indexed citations
5.
Roumiguié, M., Thomas Seisen, A. Masson-Lecomte, et al.. (2024). French AFU Cancer Committee Guidelines – Update 2024–2026: Upper urinary tract urothelial cancer (UTUC). PubMed. 34(12). 102722–102722. 1 indexed citations
6.
Roumiguié, M., Gautier Marcq, Y. Neuzillet, et al.. (2024). French AFU Cancer Committee Guidelines – Update 2024–2026: Muscle-invasive bladder cancer (MIBC). PubMed. 34(12). 102741–102741.
7.
Roumiguié, M., Priscilla Léon, Évanguelos Xylinas, et al.. (2024). French AFU Cancer Committee Guidelines – Update 2024–2026: Non-muscle invasive bladder cancer (NMIBC). PubMed. 34(12). 102742–102742.
8.
Barthélémy, Philippe, Yohann Loriot, Aude Fléchon, et al.. (2023). 2379P AVENANCE: Subgroup analysis of patients (pts) with advanced urothelial carcinoma (aUC) with histological variants from a real-world (RW) study of avelumab first-line maintenance (1LM). Annals of Oncology. 34. S1211–S1212. 2 indexed citations
9.
Colomba, Émeline, Luca Campedel, Clément Dumont, et al.. (2022). Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study. Cancers. 14(7). 1678–1678. 7 indexed citations
10.
Kretschmer, Alexander, Roderick C.N. van den Bergh, Alberto Martini, et al.. (2021). Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives. Cancers. 14(1). 147–147. 7 indexed citations
11.
Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2021). How did we take care of our older cancer patients during the first COVID-19 wave? The French experience. Bulletin du Cancer. 108(6). 589–595. 1 indexed citations
12.
Carril-Ajuria, Lucía, Émeline Colomba, Luigi Cerbone, et al.. (2021). Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma. European Journal of Cancer. 151. 106–114. 24 indexed citations
13.
Auclin, Édouard, Brigitte Laguerre, Mathilde Cancel, et al.. (2021). Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer. Cancer Medicine. 10(18). 6304–6309. 7 indexed citations
14.
Hélissey, Carole, Anatole Cessot, Laurys Boudin, et al.. (2020). Evaluation of medical practices in oncology in the context of the COVID‐19 pandemic in France: Physicians’ point of view: the PRATICOVID study. Cancer Medicine. 9(23). 8875–8883. 6 indexed citations
15.
Kretschmer, Alexander, Guillaume Ploussard, Isabel Heidegger, et al.. (2020). Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review. European Urology Focus. 7(4). 742–751. 25 indexed citations
16.
Marra, Giancarlo, Massimo Valério, Isabel Heidegger, et al.. (2020). Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review. European Urology Oncology. 3(5). 565–581. 43 indexed citations
17.
Auclin, Édouard, Adrien Procureur, Audrey Simonaggio, et al.. (2020). Cabazitaxel Schedules in Metastatic Castration-Resistant Prostate Cancer: A Review. Future Oncology. 17(1). 91–102. 6 indexed citations
18.
Deshayes, Emmanuel, M. Roumiguié, Constance Thibault, et al.. (2017). Radium 223 dichloride for prostate cancer treatment. Drug Design Development and Therapy. Volume 11. 2643–2651. 68 indexed citations
19.
Thibault, Constance, et al.. (2016). Long-term use of sunitinib in metastatic renal cell carcinoma: no unpleasant surprises about tolerability. Translational Cancer Research. 5(2). 1 indexed citations
20.
Pécuchet, Nicolas, Eleonora Zonta, Audrey Didelot, et al.. (2016). Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study. PLoS Medicine. 13(12). e1002199–e1002199. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pınar Saip Breakdown of academic impact, for papers by Kent Kanao Breakdown of academic impact, for papers by Mehmet Alı Nahıt Şendur Breakdown of academic impact, for papers by Begoña de las Heras Breakdown of academic impact, for papers by Loı̈c Mourey Breakdown of academic impact, for papers by Abdurrahman Işıkdoğan Breakdown of academic impact, for papers by Florian Kocher Breakdown of academic impact, for papers by Daniel Swinson Breakdown of academic impact, for papers by Melissa Bersanelli Breakdown of academic impact, for papers by Timothy R. Asmis
Rankless by CCL
2026